Protein N-e-acetylation is recognized as an important modification influencing many biological processes, and protein deacetylase inhibitors leading to N-e-hyperacetylation of histones are being clinically tested for their potential as anticancer drugs. In contrast to N-eacetyltransferases, the N-a-acetyltransferases transferring acetyl groups to the a-amino groups of protein N-termini have only been briefly described in mammalians. Human arrest defective 1 (hARD1), the only described human enzyme in this class, complexes with N-acetyltransferase human (NATH) and cotranslationally transfers acetyl groups to the N-termini of nascent polypeptides. Here, we demonstrate that knockdown of NATH and/or hARD1 triggers apoptosis in human cell lines. Knockdown of hARD1 also sensitized cells to daunorubicin-induced apoptosis, potentially pointing at the NATH-hARD1 acetyltransferase complex as a novel target for chemotherapy. Our results argue for an essential role of the NATH-hARD1 complex in cell survival and underscore the importance of protein N-aacetylation in mammalian cells.
Introduction
While a large fraction of mammalian proteins is N-aacetylated, no publications have to date reported on the phenotypic consequences of protein N-a-acetylation in humans. An extensive review of eukaryotic N-terminal acetyltransferases was recently published (Polevoda and Sherman, 2003) . In yeast, N-acetyltransferase 1 protein (Nat1p) and Arrest defective 1 protein (Ard1p) form a functional N-a-acetyltransferase complex (NatA) (Park and Szostak, 1992) , which specifically acetylates serine-, threonine-, glycine-or alanine-N-termini after the initial methionine has been cleaved off by aminopeptidases during translation (Polevoda et al., 1999) . Defects in G0-entry, reduced cell growth and defect sporulation are among the phenotypes found in Saccharomyces cerevisiae ard1 and nat1 null strains (Whiteway and Szostak, 1985; Whiteway et al., 1987; Lee et al., 1989; Mullen et al., 1989) . A recent full-genome RNA interference (RNAi) profiling of Caenorhabditis elegans revealed that knockdown of both the ard1 and nat1 orthologues resulted in embryonic lethality (Sonnichsen et al., 2005) , whereas in the parasite Trypanosoma brucei, the ard1 gene was found to be essential for growth (Ingram et al., 2000) . These observations point to a possible role of the protein N-a-acetyltransferase complex in cell proliferation and survival.
The human NATH gene was identified and demonstrated to be overexpressed in papillary thyroid carcinomas, especially in clinically aggressive and undifferentiated tumours (Fluge et al., 2002) . These in vivo observations point to a possible growth advantage of tumour cells overexpressing the NATH gene. We recently showed that hARD1 and NATH, the human orthologues of yeast Ard1 and Nat1, form an enzymatically active N-a-acetyltransferase complex (Arnesen et al., 2005a) . During apoptosis induced by daunorubicin, a major first-line drug in the treatment of acute myeloid leukaemia, both NATH and hARD1 are specifically cleaved by caspases and the N-a-acetylation activity of the complex is reduced in the complex containing the NATH and hARD1 cleavage products (Arnesen et al., 2005a) .
A mechanistic link between e-acetylation of lysine residues within proteins and apoptosis has been recognized since many years (reviewed in Di Gennaro et al., 2004) . Significantly, histone deacetylase (HDAC) inhibitors result in hyperacetylation of histones, transcription factors and other proteins. This affects the expression of genes involved in cell cycle control, apoptosis, and DNA synthesis (Di Gennaro et al., 2004) .
Here, we report that in HeLa cells, small interfering RNA (siRNA)-mediated knockdown of the NATH-hARD1 N-a-acetyltransferase complex induces apoptosis and also sensitizes cells to daunorubicininduced apoptosis. Our data shed new light on the role of protein N-a-acetylation in human cells and identify the human NATH-hARD1 N-a-acetyltransferase complex as a potential novel target for cancer treatment.
Results

siRNA-mediated knockdown of NATH and hARD1
Knockdown of endogenous NATH and hARD1 in HeLa cells, was obtained by NATH and hARD1 mRNAspecific siRNA transfection. siRNA specific to Lamin A/ C (siL) was used as a control of transfection efficiency and as a control of normal levels of NATH and hARD1 mRNA proteins (Figure 1) . Two different siRNAs (siA1-1, -2 and siN-1, -2) specific for hARD1 and NATH, respectively, were found effective in reducing the mRNA level of hARD1 and NATH. A significant reduction of the hARD1 and NATH mRNA levels was observed 24 h post-transfection as analysed by RT-PCR (Figure 1a and b). Correspondingly, the level of hARD1 and NATH proteins was significantly reduced 24-48 h after hARD1-and NATH-specific siRNA transfection ( Figure  1c and d) . In general, the reduction of the NATH protein was slower than that of hARD1 protein following siRNA treatment, indicating that the NATH protein has a longer half-life than hARD1.
Knockdown of NATH and hARD1 reduces cell viability
To determine whether NATH and hARD1 proteins were involved in cell proliferation, we assayed siN-and siA1-transfected HeLa cells by using the WST-1 cell viability/proliferation assay. After 48 h of treatment, both NATH and hARD1 knockdown significantly reduced the percentage (46-55%) of viable HeLa cells as compared to the siL-treated cells (Figure 2a) . Lamin A/C has been demonstrated to be nonessential to cultured human cells and, is therefore, a valid control of cell viability (Harborth et al., 2001) . NATH and hARD1 knockdown caused approximately the same degree of reduction in cell viability, indicative of a common pathway of function. Transfection experiments using siN and siA1 in combination showed neither additive nor synergistic effects (Figure 2b) . Thus, the effect on viability of NATH and hARD1 knockdown seems to be due to a decrease in functional NATHhARD1 N-a-acetyltransferase complexes.
Ard1 and Nat1 in yeast have been suggested to control the G0 entry, and ard1 and nat1 null mutants were found to have a more severe loss of viability under nutrient-limited conditions (Whiteway and Szostak, 1985) . We, therefore, performed knockdown of hARD1 and NATH under reduced serum conditions. Starvation, using 0.1% serum, combined with hARD1, NATH, or combined hARD1 þ NATH knockdown resulted in 50, 29, and 30% reduction, respectively, of cell viability as compared to cells cultured at 10% serum ( Figure 2c ). We then tested if overexpression of hARD1 and NATH could positively affect cell viability under normal serum conditions or starvation (Figure 2d ). In the presence of serum, overexpression of hARD1 and NATH, alone or in combination, slightly affected the cell viability positively, whereas no effect was observed under starving conditions.
Knockdown of NATH and hARD1 induces apoptosis
The reduced cell viability could be caused by reduced proliferation or an increase of apoptosis. To investigate whether or not the reduced cell viability was due to increased apoptosis, we transfected HeLa cells with siA1 or siN RNA and cultured the cells for 48 h before fixation and May-Gru¨nwald-Giemsa-staining. Counting of cells having pycnotic nuclei characteristic for apoptotic cells was performed in four parallels ( Figure  3a and b) . Statistical analysis revealed a significant increase in dead cells in both siN and siA1 treated cultures. To test for possible additive or synergistic effects of the combined siA1 and siN treatment, simultaneous knockdown of hARD1 and NATH was performed. Double siA1/siN transfections showed no significant increases in cell death as compared to singly transfected cells (Figure 3a) . These results indicate that the mechanism(s) inducing cell death may be common for hARD1 and NATH knockdown cells. Support for the induction of apoptosis was found using TUNEL assay detecting free 3 0 OH DNA ends. Cell cultures treated with siA1-1 showed a significantly higher percentage of TUNEL-positive cells than control cells (Figure 4 ). To further verify that the cells with . After 48 h, cell viability was determined by WST-1 assay. The data are presented as the mean7s.d. for three or four independent experiments with the values of the placZ experiments defined as 100%. Pvalues for independent t-tests for samples versus placZ (in 10% FBS) are indicated for phARD1, pNATH and phARD1 þ pNATH samples as (*)o0.0108, (**)o0.0018, and (***)o0.014, respectively.
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morphological features typical of apoptosis indeed were undergoing apoptosis, we assayed siA1-and siN-treated cells for caspase-3 activity ( Figure 5a ). An approximate twofold increase in caspase activity was observed in both single-transfected cells and in combined siA1/siNtreated cells as compared to control cells. Furthermore, the same cell lysates used for the caspase-3 assays were analysed for increased cleavage of the caspase-3 and caspase-7 substrate poly (ADP-ribose) polymerase (PARP) (Figure 5b ). Strong bands specific for the cleaved form of PARP were observed in cell extracts from siA1-, siN-and siA1/siN-treated cells. These results were consistent with the observed decreased cell viability and increased caspase activity. Significant increase in cell death was observed by light microscopy in siA1-treated cells, 20, 50, and 100 nM, as compared to control cells (data not shown). Strong PARP-cleavage was detected over the same range of siA1 concentration ( Figure 5c ). To determine if the observed apoptosis was caspasedependent, we inhibited caspase activity by adding the pancaspase inhibitor Z-Val-Ala-Asp-fluormethylketon (Z-VAD-fmk) to siA1-or siN-transfected cells and used the WST-1 cell proliferation assay to assess cell viability. Z-VAD-fmk treatment increased cell viability of both siA1-and siN-treated as compared to untreated cell cultures ( Figure 5d ). We then stained siA1-and siNtreated cells with anti-Annexin V antibody and propidium iodide to discriminate viable from apoptotic cells. The results (Figure 5e ) confirmed that hARD1 and NATH knockdown increased apoptosis of HeLa cells. Regular flow cytometric cell cycle analysis revealed a slight increase in the sub-G0/G1 for hARD1 and NATH knockdown cells, representing apoptosis at 72 h posttransfection (Table 1) . By light microscopy, the siA1/N cells displayed significant apoptosis as compared to control cells at both 48 and 72 h post-transfection (data not shown). After 72 h of treatment, the fraction of cells in G0/G1 was reduced (Table 1 ). This might indicate that the apoptotic cells were derived from the G0/G1 cells. When apoptosis was blocked by Z-VAD-fmk, the fraction of G0/G1 cells increased both at 48 and 72 h as compared to Z-VAD-fmk-untreated cells (Table 1) .
To test whether or not the observed apoptotic effects were cell-specific, we also performed siA1-mediated hARD1 knockdown in the human glioblastoma GaMg cell line. These cells also responded by induction of apoptosis as determined by microscopic evaluation and by increased cleavage of PARP (data not shown). However, in the GaMg cells, only siA1-1 -displaying the strongest hARD1-silencing capacity -caused significant apoptosis.
Knockdown of hARD1 sensitizes cells to drug-induced apoptosis
The HeLa cell line subclone, HeLaS3, is significantly more resistant to apoptosis induced by siA1 treatment than the wild-type HeLa cell line. We, therefore, used this phenotype of HeLaS3 cells to test whether or not knockdown of hARD1 would make this cell line more sensitive to the DNA-damaging reagent daunorubicin. HeLaS3 cells were first treated with siA1-1 or siL as the negative control, and then the cells were treated with 5 mM or increasing concentrations of daunorubicin (Figure 6a and b) . The data clearly demonstrated increased apoptosis of HeLaS3 cells treated with siA Knockdown of hARD1 reduces the NATH-hARD1-mediated N-a-acetyltransferase activity To investigate whether the NATH-hARD1-associated N-a-acetyltransferase activity was reduced in siA1-treated cells, we immunoprecipitated NATH-hARD1 complexes and determined the N-a-acetyltransferase activity (Figure 7 ). Immunoprecipitated NATH complexes from siA1-transfected cells expressed significantly reduced N-a-acetyltransferase activity as compared to untreated controls (Figure 7 ). In these experiments, siA1-treated cells displayed a significant reduction in the hARD1 protein level, whereas the level of NATH was unaltered ( Figure 7 ). The addition of Z-VAD-fmk at a concentration (20 mM) that inhibited apoptosis did not restore the protein N-a-acetyltransferase activity (data not shown).
Discussion
We previously demonstrated that NATH and hARD1 are active as a protein N-a-acetyltransferase in a heterocomplex (Arnesen et al., 2005a) . Our present observation that siRNA-mediated knockdown of NATH and hARD1 affected negatively cell viability indicates that N-a-acetylation of proteins may play a hitherto unidentified role in maintaining the balance between cell survival and cell death. In analogy to the yeast Ard1-Nat1 (Polevoda et al., 1999) , proteins with Nterminal serine, threonine, alanine, or glycine residues are likely candidates to be less acetylated in the NATHhARD1-knockdown cells. Insufficient protein N-a-acetylation may lead to altered stability or function of specific target proteins generating a more apoptosis-prone phenotype. In contrast, apoptosis induced by HDAC inhibitors is linked to hyperacetylation of e-amino groups of histones and other proteins (Di Gennaro et al., 2004) . Thus, it is likely that the observed cell death induced by hARD1 or NATH knockdown is not mechanistically linked to changes in e-acetylation of proteins. However, further studies addressing this question are needed.
As the NATH-hARD1 complex is associated with ribosome (Gautschi et al., 2003; Arnesen et al., 2005a) and the N-terminal acetylation is a cotranslational process (Driessen et al., 1985) , it would be expected that NATH-hARD1 affect apoptosis through the ribosomal-linked acetylation activity. Regulation of protein synthesis has in recent years been strongly linked to cell survival or apoptosis. Post-translational modifications of several translation-initiation factors, elongation factors, and factors regulating mRNA usage contribute to activation of apoptosis through translational changes, reducing the levels of proteins protecting against apoptosis or increasing the levels of proapoptotic factors (reviewed in Morley et al., 2005) . Also, several components of the translational machinery are cleaved and inactivated during apoptosis (reviewed in Fischer et al., 2003) . Our present results concerning cotranslational N-a-acetylation of nascent polypeptide chains also identify this downstream stage of ribosomal activity to potentially play a role in the regulation of apoptosis. Previously, we observed that both NATH and hARD1 proteins were cleaved by caspases during apoptosis in HeLa and promyelocytic leukaemia NB4 cells (Arnesen et al., 2005a) . This can probably be regarded as proapoptotic event as the loss of functional NATHhARD1 complexes coincides with increased cell death.
In the course of the present study, it was generally observed that siA1 gave a somewhat stronger phenotypic effect than siN. This could be explained by our observation that the NATH protein appeared to be more stable than hARD1 and a longer time period was required to deplete the cell of NATH protein than for hARD1 protein (Figure 1c and d) . The importance of near complete knockdown of in particular hARD1 to obtain apoptotic response was noticed. This phenomenon also corresponds to the need of total hARD1 knockdown in GaMg cells in order to see induction of apoptosis. The effect of siN/siA1 seemed to exhibit a certain degree of cell type dependency. The HeLa and GaMg cell lines responded qualitatively similar to hARD1 knockdown, whereas the HeLaS3 subclone only demonstrated weak apoptotic phenotype upon siA1 treatment. A difference in sensitivity to the loss of NATH-hARD1 complexes could be an important factor and only if the proteins that are N-a-acetylated by NATH-hARD1 play a role in protecting against apoptosis in the particular cell type, a strong apoptotic phenotype would be expected.
Cells grown at limiting serum conditions were more sensitive to hARD1-NATH knockdown than cells grown at high serum. The NATH-hARD1 knockdown and lack of growth signals in combination could synergistically reduce the cell viability. Importantly, yeast Ard1 and Nat1 have been implicated in the control 
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of G0-entry and to regulate the cell entry into different fates (Whiteway and Szostak, 1985) . Thus, a role for hARD1-NATH regulating a cell cycle checkpoint in the G1 phase cannot be excluded. This could also explain the phenotypic results observed as dysregulation of the cell cycle often results in apoptosis. Our cell cycle analyses using HeLaS3 cells demonstrated only a weak accumulation of cells in the G0/G1 phase in response to human NatA (hARD1-NATH) knockdown. For HeLa cells where apoptosis is induced, a reduction in G0/G1 phase is observed, whereas the addition of Z-VAD-fmk increases the relative fraction of G0/G1 cells. Even though these experiments suggest a consistent effect on cell cycle traverse, our data do not conclusively link knockdown of hARD1-NATH to dysregulation of the traverse through G0/G1. However, these findings point to cell cycle regulation as interesting for future experiments aimed at elucidating the detailed mechanism of hARD1-NATH knockdown-mediated apoptosis.
The addition of Z-VAD-fmk to siRNA-treated HeLa cells restored the viability of NATH/hARD1-knockdown cells. This suggests that induction of apoptosis is the major cause of the reduced cell viability observed for siN/siA1-treated cells. A recent study demonstrated that hARD1 knockdown resulted in a reduction of cell proliferation (Fisher et al., 2005) , but this latter study anti-NATH anti-hARD1 Figure 7 Reduction of the protein N-a-acetyltransferase activity of the NATH-hARD1 complex. HeLa cells were transfected with the indicated siRNA for 24 h. The resulting cell lysates were immunoprecipitated (IP) using anti-NATH or negative control antibodies. The beads containing NATH-complexes were analysed for N-a-acetyltransferase activity (Materials and methods). Immunoprecipitation beads, and cell lysates removed before immunoprecipitation, were analysed by SDS-PAGE and Western blotting using anti-hARD1 and anti-NATH antibodies. Results shown are representative of three independent experiments. Downregulation of hARD1-NATH triggers apoptosis T Arnesen et al did not address effects on apoptosis or on specific cell cycle phases.
NATH and hARD1 are both downregulated at the protein level in NB4 cells undergoing differentiation (Arnesen et al., submitted) . Other studies also link these two genes to differentiation (Midorikawa et al., 2002; Sugiura et al., 2003) . Retinoic-acid-treated NB4 cells undergo terminal differentiation with apoptosis as an end point (Benoit et al., 1999) . In the light of our present results, we may hypothesize that the reduction of NATH and hARD1 during differentiation facilitates a postdifferentiation apoptotic fate.
The mouse ARD1 has been suggested to e-acetylate and mediate the degradation of hypoxia-inducible factor-1a (HIF-1a) (Jeong et al., 2002) . A decrease in the hARD1 level could be expected to stabilize HIF-1a and thereby activate HIF-1a-regulated downstream genes. Some of these genes have been reported to induce apoptosis (Sowter et al., 2001) . We found that siRNA-mediated knockdown of hARD1 did not affect the level of endogenous HIF-1a protein in HeLa cells (Arnesen et al., 2005c) . Thus, the sensitization of HeLa cells to apoptosis, by decreased hARD1 or NATH levels, is probably an HIF-1a-independent phenomenon. The role of hARD1 in regulating HIF-1a stability has also been disputed by other investigators (Bilton et al., 2005; Fisher et al., 2005) .
In cancer chemotherapy, multidrug treatment is commonly used to achieve optimal treatment response. The down-regulation of hARD1 proved to be an effective means to sensitize HeLa cells to daunorubicin-induced cell death ( Figure 6 ). This unique observation opens the possibility of new strategies for cancer treatment. Inhibition of hARD1-mediated protein N-aacetylation in combination with specific drug treatment may increase drug effects and reduce unwanted toxic side effects as lower doses of drug can be employed. Furthermore, our present finding that protein N-aacetylation plays an important role in protecting against cell death argues for specific hARD1 substrates to represent important cancer drug targets. Experiments to identify such targets should be a future priority.
In summary, we have demonstrated that reduced levels of the NATH-hARD1 complex, which in its active form mediates nascent polypeptide N-a-acetylation, render human cell lines more prone to enter the apoptotic pathway. This novel finding potentially adds additional importance to ribosomal-linked mechanisms of apoptosis. Future studies should focus on the identification of apoptosis-related substrates of the NATH-hARD1 protein N-a-acetylation and to understand the detailed mechanism by which apoptosis is triggered as a consequence of NATH-hARD1 depletion. Our present study identifies the NATH-hARD1 complex as a potential drug target in cancer chemotherapy.
Materials and methods
Cell culture and transfections
HeLa, HeLaS3 and GaMg cells were cultured at 37 o C, 5% CO 2 in DMEM supplemented with 10% FBS and 3% l-glutamine. Plasmid transfections were performed using Fugene6 (Roche) and 100 nM of gene-specific siRNA (Dharmacon, Inc., Lafayette, CO, USA) was added to the cells, using Oligofectamine (Invitrogen, Carlsbad, CA, USA) according to the supplier's manual. The following siRNA duplex target sequences were used: siA1-1, CCA GAU GAA AUA CUA CUU C; siA1-2, CUU UCA GAU CAG UGA AGU G; siN-1, GGG ACC UUU CCU UAC UAC A; siN-2, GAA GCU GCU GAA AUU UAU A; siLamin A/C, GGU GGU GAC GAU CUG GGC U.
RT-PCR
Isolation of mRNA and RT-PCR was performed as described previously (Arnesen et al., 2005b) . The following primers were used for detection of specific genes: hARD1-For, Western blotting SDS-gel electrophoresis and Western blotting were performed as described (Arnesen et al., 2005b) . Polyclonal rabbit antibodies against NATH and hARD1 (Arnesen et al., 2005a) were used at 1:500 dilution, anti-b-tubulin (Sigma) 1:1000, anti-cleaved-PARP (Upstate) 1:500. Horseradish peroxidase-linked anti-mouse and anti-rabbit were from Amersham Lifescience, UK.
Cell viability assay
Cells growing in a 96-well plate were transfected with siRNAs or plasmids for 48 h as described above. WST-1 reagent (diluted 1:10 in growth medium) was added for the last 2-4 h as described in the instruction manual (Roche, Mannheim, Germany). Viable cell mass was determined by the optical density measurement by a FLUOstar OPTIMA (BMG labtech GmbH, Offenburg, Germany) microplate reader at 420 nm, using 600 nm as a reference wavelength. In the phenotypereversion experiment (Figure 5d ), siRNA transfection was carried out for 24 h in total and Z-VAD-fmk (20 mM) was added at 4 and 12 h. TUNEL assay HeLa cells growing on coverslips were transfected by 100 nM siRNA directed to hARD1, lamin A/C or untransfected. After 48 h, the cells were rinsed with PBS and fixed for 1 h at a room temperature in 4% paraformaldehyde. Cells were permeabilized for 2 min on ice in 0.1% Triton X-100 in sodium citrate and then incubated with TUNEL reaction mixture (In situ Cell Death Detection Kit, TMR red, Roche) for 1 h at 371C. For each sample (hARD1-, lamin A/C-knockdown and untransfected cells), positive and negative controls were carried out by treating samples with DNaseI or incubation in TUNEL Label reaction without enzyme. After staining, the cells were washed in PBS and DAPI mounting (Vectashield, Vector Laboratories) was applied to visualize nuclei. Samples were directly analysed under fluorescent microscope, Leica DM6000B with an FW4000 camera using BGR-filter. Samples were prepared in triplicates.
Acetylation assay
The assay was performed essentially as previously described (Arnesen et al., 2005a) . In brief, B10 7 cells were transfected by siRNA. At 24 h post-transfection, cells were lysed and immunoprecipitated using anti-NATH or control immunoglobulins. Beads containing NATH complexes were added substrate peptide and [ 3 -H]-Acetyl coenzyme A. After incubation for 1 h at 301C, the amount of acetylated peptide was measured by scintillation counting.
Cell cycle analysis
After harvesting by Trysin treatment, the cells were rapidly fixated in ice-cold 70% ethanol and incubated for at least 30 min at 41C. They were then washed once, resuspended in 800 ml PBS and added RNase A (Sigma) (0.1 mg/ml) and Propidium iodide (PI) (Sigma) (40 mg/ml), both in final concentrations, before they were incubated dark at 371C for 30 min. Samples were immediately analysed by flow cytometry (FACS Calibur, Becton Dickinson, San Jose, CA, USA) in their staining solution. A cytogram based on the forward light scatter versus the right angle scatter was used to eliminate aggregates, debris and dead cells, before red fluorescence (FL3) in linear mode was detected on viable cells. For each measurement, 50 000 events were aquired. Data were analysed using Cell Quest Lysis II software (Becton Dickinson, BD, Franklin Lakes, NJ, USA). Results are representative of three independent experiments.
Analysis of apoptosis by flow cytometric analysis Double staining of HeLa cells with Annexin V-FITC and PI was used to discriminate viable from apoptotic and dead cells (Ryningen et al., 2005) . Fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI) were obtained as a kit (A700) from Tau Technologies. Cultured cells were collected by centrifugation and washed once with cold PBS, centrifuged and resuspended in binding buffer (in the A700 kit), and incubated together with a final concentration of 0.25 mg/ml Annexin V-FITC for 15 min until 2.5 mg/ml PI (final concentration) were added and cells analysed by flow cytometry (FACS Calibur, Becton Dickinson, San Jose, CA, USA) 5 min later. This protocol leads to some loss of apoptotic cells, compared to direct staining experiments. For each measurement 10 000 events were collected, and cells were gated as viable, apoptotic, necrotic or as apoptotic vesicles, based on both their light scatter signals and their mean fluorescence intensities on FL1 (Annexin V) and FL3 (PI). Data were analysed using Cell Quest Lysis II software (Becton Dickinson).
